These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Hydroxysafflor yellow A promotes neovascularization and cardiac function recovery through HO-1/VEGF-A/SDF-1α cascade. Wei G; Yin Y; Duan J; Guo C; Zhu Y; Wang Y; Xi M; Wen A Biomed Pharmacother; 2017 Apr; 88():409-420. PubMed ID: 28122306 [TBL] [Abstract][Full Text] [Related]
11. Plasma vascular endothelial growth factor (VEGF) levels after intramuscular and intramyocardial gene transfer of VEGF-1 plasmid DNA. Freedman SB; Vale P; Kalka C; Kearney M; Pieczek A; Symes J; Losordo D; Isner JM Hum Gene Ther; 2002 Sep; 13(13):1595-603. PubMed ID: 12228014 [TBL] [Abstract][Full Text] [Related]
12. Effects of Puerarin on Clinical Parameters, Vascular Endothelial Function, and Inflammatory Factors in Patients with Coronary Artery Disease. Zhang S; Chen L; Zhou Z; Fan W; Liu S Med Sci Monit; 2019 Jan; 25():402-408. PubMed ID: 30636768 [TBL] [Abstract][Full Text] [Related]
13. Gene transfer of stromal cell-derived factor-1alpha enhances ischemic vasculogenesis and angiogenesis via vascular endothelial growth factor/endothelial nitric oxide synthase-related pathway: next-generation chemokine therapy for therapeutic neovascularization. Hiasa K; Ishibashi M; Ohtani K; Inoue S; Zhao Q; Kitamoto S; Sata M; Ichiki T; Takeshita A; Egashira K Circulation; 2004 May; 109(20):2454-61. PubMed ID: 15148275 [TBL] [Abstract][Full Text] [Related]
14. Interleukin-1alpha promotes angiogenesis in vivo via VEGFR-2 pathway by inducing inflammatory cell VEGF synthesis and secretion. Salven P; Hattori K; Heissig B; Rafii S FASEB J; 2002 Sep; 16(11):1471-3. PubMed ID: 12205052 [TBL] [Abstract][Full Text] [Related]
15. Tumor necrosis factor-α-activated mesenchymal stem cells promote endothelial progenitor cell homing and angiogenesis. Kwon YW; Heo SC; Jeong GO; Yoon JW; Mo WM; Lee MJ; Jang IH; Kwon SM; Lee JS; Kim JH Biochim Biophys Acta; 2013 Dec; 1832(12):2136-44. PubMed ID: 23959047 [TBL] [Abstract][Full Text] [Related]
16. Targeting tumor micro-environment for design and development of novel anti-angiogenic agents arresting tumor growth. Gacche RN; Meshram RJ Prog Biophys Mol Biol; 2013 Nov; 113(2):333-54. PubMed ID: 24139944 [TBL] [Abstract][Full Text] [Related]
17. Hypoxic stress simultaneously stimulates vascular endothelial growth factor via hypoxia-inducible factor-1α and inhibits stromal cell-derived factor-1 in human endometrial stromal cells. Tsuzuki T; Okada H; Cho H; Tsuji S; Nishigaki A; Yasuda K; Kanzaki H Hum Reprod; 2012 Feb; 27(2):523-30. PubMed ID: 22128293 [TBL] [Abstract][Full Text] [Related]
18. Ultrasound-targeted gene delivery induces angiogenesis after a myocardial infarction in mice. Fujii H; Sun Z; Li SH; Wu J; Fazel S; Weisel RD; Rakowski H; Lindner J; Li RK JACC Cardiovasc Imaging; 2009 Jul; 2(7):869-79. PubMed ID: 19608138 [TBL] [Abstract][Full Text] [Related]
19. Neuropeptide Y Y5-receptor activation on breast cancer cells acts as a paracrine system that stimulates VEGF expression and secretion to promote angiogenesis. Medeiros PJ; Jackson DN Peptides; 2013 Oct; 48():106-13. PubMed ID: 23932937 [TBL] [Abstract][Full Text] [Related]
20. High-dose plasmid-mediated VEGF gene transfer is safe in patients with severe ischemic heart disease (Genesis-I). A phase I, open-label, two-year follow-up trial. Favaloro L; Diez M; Mendiz O; Janavel GV; Valdivieso L; Ratto R; Garelli G; Salmo F; Criscuolo M; Bercovich A; Crottogini A Catheter Cardiovasc Interv; 2013 Nov; 82(6):899-906. PubMed ID: 22777825 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]